Sojourn Hospice And Palliative Care - Fresno 1318 E Shaw Ave Ste 100, Fresno, CA, 93710 | |
(408) 781-2623 |
News Archive
Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston, MA on Wednesday, September 9, 2009 at 3:50 p.m. ET.
Kessler Foundation is participating in a phase II multi-site study of an innovative treatment to improve hand function in stroke survivors. Olga Boukrina, PhD, research scientist in the Center for Stroke Rehabilitation Research, is the site's principal investigator.
Children with Kawasaki disease show a pattern of changing laboratory test results as the disease runs its course, according to a study in the December issue of The Pediatric Infectious Disease Journal.
Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).
A Brazilian scorpion has provided researchers at North Carolina State University and East Carolina University insight into venom's effects on the ability of certain cells to release critical components. The findings may prove useful in understanding diseases like pancreatitis or in targeted drug delivery.
› Verified 8 days ago
Name | Sojourn Hospice And Palliative Care - Fresno |
---|---|
Location | 1318 E Shaw Ave Ste 100, Fresno, California |
Hospice ID | 751518 |
Category | Freestanding Hospice |
Ownership Type | Other |
Profit Type | OTHER |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 090 |
News Archive
Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston, MA on Wednesday, September 9, 2009 at 3:50 p.m. ET.
Kessler Foundation is participating in a phase II multi-site study of an innovative treatment to improve hand function in stroke survivors. Olga Boukrina, PhD, research scientist in the Center for Stroke Rehabilitation Research, is the site's principal investigator.
Children with Kawasaki disease show a pattern of changing laboratory test results as the disease runs its course, according to a study in the December issue of The Pediatric Infectious Disease Journal.
Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).
A Brazilian scorpion has provided researchers at North Carolina State University and East Carolina University insight into venom's effects on the ability of certain cells to release critical components. The findings may prove useful in understanding diseases like pancreatitis or in targeted drug delivery.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston, MA on Wednesday, September 9, 2009 at 3:50 p.m. ET.
Kessler Foundation is participating in a phase II multi-site study of an innovative treatment to improve hand function in stroke survivors. Olga Boukrina, PhD, research scientist in the Center for Stroke Rehabilitation Research, is the site's principal investigator.
Children with Kawasaki disease show a pattern of changing laboratory test results as the disease runs its course, according to a study in the December issue of The Pediatric Infectious Disease Journal.
Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).
A Brazilian scorpion has provided researchers at North Carolina State University and East Carolina University insight into venom's effects on the ability of certain cells to release critical components. The findings may prove useful in understanding diseases like pancreatitis or in targeted drug delivery.
› Verified 8 days ago
Home Health Aides | 1 |
Counselors | 1.5 |
Homemakers | 1 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 1 |
Other Personnel | 1 |
Total Employees | 7.5 |
---|
News Archive
Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston, MA on Wednesday, September 9, 2009 at 3:50 p.m. ET.
Kessler Foundation is participating in a phase II multi-site study of an innovative treatment to improve hand function in stroke survivors. Olga Boukrina, PhD, research scientist in the Center for Stroke Rehabilitation Research, is the site's principal investigator.
Children with Kawasaki disease show a pattern of changing laboratory test results as the disease runs its course, according to a study in the December issue of The Pediatric Infectious Disease Journal.
Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).
A Brazilian scorpion has provided researchers at North Carolina State University and East Carolina University insight into venom's effects on the ability of certain cells to release critical components. The findings may prove useful in understanding diseases like pancreatitis or in targeted drug delivery.
› Verified 8 days ago
Saint Agnes Home Health & Hospice Location: 6729 North Willow Ave Suite 103, Fresno, California, 93710 Phone: (408) 781-2623 |
Hinds Hospice - Fresno Location: 2490 W Shaw Ave, Suite 101, Fresno, California, 93711 Phone: (408) 781-2623 |
Optimal Hospice Care Location: 6780 North West Avenue, Suite 101, Fresno, California, 93711 Phone: (408) 781-2623 |
Aseracare Hospice Location: 650 West Alluvial Avenue, Fresno, California, 93711 Phone: (408) 781-2623 |